Clinical Trials Browser

Phase 2 × Suspended × Gefitinib × Clear all

NCT00986284 2015-12-22

Epidermal Growth Factor Receptor (EGFR) Status Based Gefitinib Neoadjuvant Therapy in Non Small Cell Lung Cancer (NSCLC)

Phase 2 Suspended

Carcinoma, Non-Small-Cell Lung